XML 69 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of the Business and Basis of Presentation - Schedule of Reverse Capitalization (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 10, 2021
Jun. 09, 2021
Dec. 31, 2022
Dec. 31, 2021
Reverse Capitalization, Value [Abstract]        
PIPE and SPAC financing     $ 16,824 $ 1
Reverse recapitalization       251,235
Additional Paid-In Capital        
Reverse Capitalization, Value [Abstract]        
Redemption of Class H units $ (900)      
PIPE and SPAC financing 377,654   $ 16,824 (344)
Earn-out liability (119,759)      
Transaction expenses (21,575)      
Warrants liability (74,408)      
Reverse recapitalization 251,229     $ 251,229
Embry Convertible Subordinated Notes Payable | Convertible debt | Additional Paid-In Capital        
Reverse Capitalization, Value [Abstract]        
Embry notes conversion 4,118      
Public Warrants | Additional Paid-In Capital        
Reverse Capitalization, Value [Abstract]        
Embry notes conversion 0      
Securities Subject to Mandatory Redemption | Additional Paid-In Capital        
Reverse Capitalization, Value [Abstract]        
Embry notes conversion $ 86,099      
Class A        
Reverse Capitalization, Shares [Abstract]        
SAFEs converted into Class A units (in shares)   284,925    
Class A | Common stock        
Reverse Capitalization, Shares [Abstract]        
Redemption of shares (in shares) (125,101)      
PIPE and SPAC financing (in shares) 44,797,894   2,131,759 1,725,000
Reverse recapitalization (in shares) 60,441,289     60,441,289
Reverse Capitalization, Value [Abstract]        
PIPE and SPAC financing $ 4     $ 1
Reverse recapitalization $ 6     $ 6
Class A | Embry Convertible Subordinated Notes Payable | Convertible debt | Common stock        
Reverse Capitalization, Shares [Abstract]        
SAFEs converted into Class A units (in shares) 8,023,072      
Reverse Capitalization, Value [Abstract]        
Embry notes conversion $ 1      
Class A | Public Warrants | Common stock        
Reverse Capitalization, Shares [Abstract]        
SAFEs converted into Class A units (in shares) 278,533      
Class A | Securities Subject to Mandatory Redemption | Common stock        
Reverse Capitalization, Shares [Abstract]        
SAFEs converted into Class A units (in shares) 7,466,891      
Reverse Capitalization, Value [Abstract]        
Embry notes conversion $ 1      
Class V | Common stock        
Reverse Capitalization, Shares [Abstract]        
Reverse recapitalization (in shares) 454,077     454,077
Reverse Capitalization, Value [Abstract]        
Reverse recapitalization $ 0      
Class V | Securities Subject to Mandatory Redemption | Common stock        
Reverse Capitalization, Shares [Abstract]        
SAFEs converted into Class A units (in shares) 454,077